Research in the News

FDA Approves First Therapy for High-Risk Neuroblastoma

FDA Approves First Therapy for High-Risk Neuroblastoma

(FDA.gov) – The U.S. Food and Drug Administration today approved Unituxin (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a type of cancer that most often occurs in young children. Neuroblastoma is a rare cancer...
Top 10 Medical Research Issues and Trends to Watch in 2015

Top 10 Medical Research Issues and Trends to Watch in 2015

Our friends at FasterCures prepared this list of the top 10 medical research issues and trends to watch in 2015, first appearing in The Huffington Post. Each one of these issues impacts children with cancer. (Huffington Post) – At FasterCures, we are always...
Early Progress Seen in Pediatric Immunotherapy

Early Progress Seen in Pediatric Immunotherapy

(Clinical Oncology News) – Heralded as a game-changer in adult oncology, immunotherapy is reshaping pediatric oncology too, but in very different ways. “Unlike our adult [oncology] colleagues who are looking at immunotherapy as possibly their only...
Page 1 of 512345

Pin It on Pinterest

test